Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding a specific personnel transaction and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document details a specific administrative event rather than operational or financial shifts.
Management Commentary and Unusual Items
On February 18, 2013, the Company's US Retirement Savings Plan manager processed a transaction for the acquisition of 50 ADS at $45.50 per ADS on behalf of Mr. W Louv, a Person Discharging Managerial Responsibility. Management identified this transaction as an administrative error. Consequently, the transaction is to be reversed, and Mr. Louv's interest in the issued share capital of the Company has not changed.
Investor Verification Checklist
- Confirm the reversal of the 50 ADS transaction for Mr. W Louv has been executed.
- Verify that Mr. Louv's reported shareholding remains unchanged following the administrative error.
- Note that this filing contains no financial results; refer to Form 20-F for comprehensive financial data.